生体吸収性ポリマーの市場規模、シェア、成長分析：材料タイプ別、用途別、地域別 - 産業予測 2025～2032年

生体吸収性ポリマーの世界市場規模は2023年に38億米ドルと評価され、2024年の41億9,000万米ドルから2032年には91億8,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは10.3％で成長する見通しです。

生体吸収性ポリマーの世界市場は、消費者の健康意識の高まり、ヘルスケアインフラの強化、年間3億1,000万件の大手術が行われる外科手術の増加などに後押しされ、大きく成長する見通しです。これらのポリマーは、縫合糸アンカーや干渉ネジなどの整形外科用インプラントにますます利用されるようになっており、患者の快適性を高めながら、再手術の必要性を排除しています。業界を牽引する主な動向としては、低侵襲手術のトレンドに加え、特にドラッグデリバリーや組織工学などの先端医療機器に対する需要の高まりが挙げられます。アシュランドのアイルランドでの施設拡張やBioretec社のFDA承認のRemeOs（TM）外傷用スクリューのような最近の技術革新は、生分解性と生体適合性を改善する継続的な進歩を反映しています。規制当局の支援と医療投資の増加もこの市場の成長を後押ししており、重要な臨床ニーズに対応しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制情勢
• ケーススタディ
• 技術の進歩

生体吸収性ポリマー市場規模：材料タイプ別& CAGR（2025-2032）

• 市場概要
• ポリ乳酸
• ポリヒドロキシアルカン酸
• デンプンブレンド
• ポリブチレンサクシネート
• ポリヒドロキシウレタン

生体吸収性ポリマー市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 包装
• 農業
• 医療
• 消費財
• 繊維
• その他

生体吸収性ポリマー市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Corbion NV（Netherlands）
• Evonik Industries AG（Germany）
• Foster Corporation（United States）
• KLS Martin Group（Germany）
• DSM Biomedical（United States）
• Ashland Global Holdings Inc.（United States）
• Zeus Company LLC（United States）
• Seqens（France）
• REVA Medical LLC（United States）
• Poly-Med Incorporated（United States）
• Bezwada Biomedical LLC（United States）
• Nomisma Healthcare Pvt. Ltd.（India）
• BMG Incorporated（United States）
• Polysciences Inc.（United States）
• Huizhou Foryou Medical Devices Co. Ltd.（China）
• Musashino Chemical Laboratory Ltd.（Japan）
• Henan Xinghan Biotechnology Co. Ltd.（China）
• Covestro AG（Germany）
• International Polymer Engineering（United States）
• Mitsui Chemicals（Japan）

結論と提言

Global Bioresorbable Polymers Market size was valued at USD 3.8 billion in 2023 and is poised to grow from USD 4.19 billion in 2024 to USD 9.18 billion by 2032, growing at a CAGR of 10.3% during the forecast period (2025-2032).

The global market for bioresorbable polymers is poised for significant growth, fueled by rising consumer health awareness, enhanced healthcare infrastructure, and an uptick in surgical procedures, with 310 million major surgeries performed annually. These polymers are increasingly utilized in orthopedic implants, such as suture anchors and interference screws, eliminating the need for follow-up surgeries while enhancing patient comfort. Major industry drivers include heightened demand for advanced medical devices, particularly in drug delivery and tissue engineering, alongside the trend towards minimally invasive surgeries. Recent innovations like Ashland's facility expansion in Ireland and Bioretec's FDA-approved RemeOs(TM) trauma screw reflect ongoing advancements that improve biodegradability and biocompatibility. Regulatory support and rising healthcare investments are also propelling the growth of this market, addressing critical clinical needs.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bioresorbable Polymers market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bioresorbable Polymers Market Segments Analysis

Global Bioresorbable Polymers Market is segmented by Material Type, Application and region. Based on Material Type, the market is segmented into Polylactic Acid, Polyhydroxyalkanoates, Starch Blends, Polybutylene Succinate and Polyhydroxyurethanes. Based on Application, the market is segmented into Packaging, Agriculture, Medical, Consumer Goods, Textile and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Bioresorbable Polymers Market

The Global Bioresorbable Polymers market is experiencing significant growth due to the increasing demand for environmentally sustainable materials as the world shifts away from traditional plastics. Industries such as packaging, automotive, and agriculture are actively searching for sustainable alternatives that naturally decompose, and bioresorbable polymers present an effective solution. As concerns about plastic waste escalate and regulatory pressures regarding environmental impact intensify, these innovative materials are being adopted for a variety of non-medical applications. This trend underscores the market's potential, as companies seek to align with sustainability goals while addressing the pressing issues associated with plastic pollution.

Restraints in the Global Bioresorbable Polymers Market

The Global Bioresorbable Polymers market faces certain restraints, primarily stemming from the rising preference for minimally invasive surgeries. This trend is attributed to the numerous advantages associated with these procedures, such as shorter hospital stays, quicker recovery times, and reduced pain and bleeding. As a result, there has been a notable shift away from traditional surgical methods, leading to decreased demand for various medical devices that utilize bioresorbable polymers. Laparoscopy, a widely adopted minimally invasive technique, involves creating multiple small incisions in the abdominal or pelvic regions, further contributing to this decline in demand and hindering market growth.

Market Trends of the Global Bioresorbable Polymers Market

The global bioresorbable polymers market is witnessing a significant upward trend, driven largely by the rising demand for medical applications. The unique property of these polymers to naturally degrade within the body without the need for surgical removal makes them particularly attractive for various medical uses, including drug delivery systems, tissue engineering, and surgical sutures. Additionally, their versatility extends to orthopedic implants, cardiovascular devices, and wound healing applications. As healthcare continues to evolve with an aging population and a growing preference for minimally invasive procedures, the market for bioresorbable polymers is poised for substantial growth, reflecting a robust alignment with contemporary healthcare needs.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Bioresorbable Polymers Market Size by Material Type & CAGR (2025-2032)

• Market Overview
• Polylactic Acid
• Polyhydroxyalkanoates
• Starch Blends
• Polybutylene Succinate
• Polyhydroxyurethanes

Global Bioresorbable Polymers Market Size by Application & CAGR (2025-2032)

• Market Overview
• Packaging
• Agriculture
• Medical
• Consumer Goods
• Textile
• Others

Global Bioresorbable Polymers Market Size & CAGR (2025-2032)

• North America (Material Type, Application)
  • US
  • Canada
• Europe (Material Type, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Material Type, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Material Type, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Material Type, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Corbion NV (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evonik Industries AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Foster Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KLS Martin Group (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DSM Biomedical (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ashland Global Holdings Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zeus Company LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Seqens (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• REVA Medical LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Poly-Med Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bezwada Biomedical LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nomisma Healthcare Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BMG Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Polysciences Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Huizhou Foryou Medical Devices Co. Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Musashino Chemical Laboratory Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Henan Xinghan Biotechnology Co. Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Covestro AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• International Polymer Engineering (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mitsui Chemicals (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations